Consistent with our findings, previous studies have shown that SOX4 is a critical transcription factor involved in the progression of multiple cancers, and it has also been found to be upregulated in mouse arthritis models and CD4 + T cells in the inflamed joints of RA patients [25–28]. This evidence concerns the gene SOX4 and cancer.